Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Masoud Ghorbani & Ramin Farhoudi. (2018) Leishmaniasis in humans: drug or vaccine therapy?. Drug Design, Development and Therapy 12, pages 25-40.
Read now
Read now
Mahreen Ameen. (2007) Cutaneous leishmaniasis: therapeutic strategies and future directions. Expert Opinion on Pharmacotherapy 8:16, pages 2689-2699.
Read now
Read now
Articles from other publishers (42)
Manuel Jesús Chan-Bacab, María Manuela Reyes-Estebanez, Juan Carlos Camacho-Chab & Benjamín Otto Ortega-Morales. (2021) Microorganisms as a Potential Source of Molecules to Control Trypanosomatid Diseases. Molecules 26:5, pages 1388.
Crossref
Crossref
Daniel S. Dias, Patrícia A.F. Ribeiro, Vívian T. Martins, Daniela P. Lage, Áquila S.B. Portela, Lourena E. Costa, Beatriz C.S. Salles, Mariana P. Lima, Fernanda F. Ramos, Thaís T.O. Santos, Rachel B. Caligiorne, Miguel A. Chávez-Fumagalli, Julia A.G. Silveira, Danielle F. Magalhães-Soares, Denise U. Gonçalves, Jamil S. Oliveira, Bruno M. Roatt, Mariana C. Duarte, Daniel Menezes-Souza, Eduardo S. Silva, Alexsandro S. Galdino, Ricardo A. Machado-de-Ávila, Antonio L. Teixeira & Eduardo A.F. Coelho. (2017) Recombinant small glutamine-rich tetratricopeptide repeat-containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis. Molecular Immunology 91, pages 272-281.
Crossref
Crossref
Hamid Iqbal, Muhammad Ishfaq, Abdul Wahab, Muhammad Naseer Abbas, Ijaz Ahmad, Ali Rehman & Muhammad Zakir. (2016) Therapeutic modalities to combat leishmaniasis, a review. Asian Pacific Journal of Tropical Disease 6:1, pages 1-5.
Crossref
Crossref
LOURENA EMANUELE COSTA, MIGUEL ANGEL CHÁVEZ-FUMAGALLI, VIVIAN TAMIETTI MARTINS, MARIANA COSTA DUARTE, DANIELA PAGLIARA LAGE, MAYARA I. S. LIMA, NATHÁLIA CRISTINA DE JESUS PEREIRA, MANUEL SOTO, CARLOS ALBERTO PEREIRA TAVARES, LUIZ RICARDO GOULART & EDUARDO ANTONIO FERRAZ COELHO. (2015)
Phage-fused epitopes from
Leishmania infantum
used as immunogenic vaccines confer partial protection against
Leishmania amazonensis
infection
. Parasitology 142:10, pages 1335-1347.
Crossref
Crossref
Lan He, Qian Yu, Wen-Jie Zhang, Qing-Li Zhang, Li-Zhe Fan, Xiao-Yan Miao, Muhammad Kasib Khan, Min Hu, Yan-Qin Zhou & Jun-Long Zhao. (2014) Molecular cloning and characterization of a novel heat shock protein 20 of Babesia orientalis. Veterinary Parasitology 204:3-4, pages 177-183.
Crossref
Crossref
Tejinder Kaur, Ankita Thakur & Sukhbir Kaur. (2012) Protective immunity using MPL-A and autoclaved Leishmania donovani as adjuvants along with a cocktail vaccine in murine model of visceral leishmaniasis. Journal of Parasitic Diseases 37:2, pages 231-239.
Crossref
Crossref
T.T.H. Pham, P.M. Loiseau & G. Barratt. (2013) Strategies for the design of orally bioavailable antileishmanial treatments. International Journal of Pharmaceutics 454:1, pages 539-552.
Crossref
Crossref
M. L. Detoni, M. R. Fessel, A. C. R. G. Maia, G. N. Porcino, L. R. Quellis, P. Faria-Pinto, M. J. Marques, M. A. Juliano, L. Juliano, V. A. Diniz, S. Côrte-Real, S. C. Gonçalves-da-Costa, C. S. F. Souza & E. G. Vasconcelos. (2013) An antigenic domain of the Leishmania amazonensis nucleoside triphosphate diphosphohydrolase (NTPDase 1) is associated with disease progression in susceptible infected mice. Parasitology Research 112:8, pages 2773-2782.
Crossref
Crossref
Vivian T. Martins, Miguel A. Chávez-Fumagalli, Lourena E. Costa, Adriana M. C. C. Martins, Paula S. Lage, Daniela P. Lage, Mariana C. Duarte, Diogo G. Valadares, Rubens D. M. Magalhães, Tatiana G. Ribeiro, Ronaldo A. P. Nagem, Wanderson D. DaRocha, Wiliam C. B. Régis, Manuel Soto, Eduardo A. F. Coelho, Ana Paula Fernandes & Carlos A. P. Tavares. (2013) Antigenicity and Protective Efficacy of a Leishmania Amastigote-specific Protein, Member of the Super-oxygenase Family, against Visceral Leishmaniasis. PLoS Neglected Tropical Diseases 7:3, pages e2148.
Crossref
Crossref
Ana Carolina Ribeiro Gomes Maia, Gabriane Nascimento Porcino, Michelle de Lima Detoni, Nayara Braga Emídio, Danielle Gomes Marconato, Priscila Faria-Pinto, Melissa Regina Fessel, Alexandre Barbosa Reis, Luiz Juliano, Maria Aparecida Juliano, Marcos José Marques & Eveline Gomes Vasconcelos. (2013) An antigenic domain within a catalytically active Leishmania infantum nucleoside triphosphate diphosphohydrolase (NTPDase 1) is a target of inhibitory antibodies. Parasitology International 62:1, pages 44-52.
Crossref
Crossref
Nirmal Kumar Ganguly & Gautam Kumar Saha. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine
603
635
.
Katrin Färber & Heidrun Moll. 2013. Drug Resistance in Leishmania Parasites. Drug Resistance in Leishmania Parasites
113
141
.
Ronald Guillermo Peláez, Carlos Enrrique Muskus Lopez, Patricia Cuervo & Marcel Marín-Villa. (2012) Expresión diferencial de proteínas en Leishmania (Viannia) panamensis asociadas con mecanismos de resistencia a antimoniato de meglumina. Biomédica 32:3.
Crossref
Crossref
Dulcilene M. Oliveira, Mariana Amália F. Costa, Miguel A. Chavez-Fumagalli, Diogo G. Valadares, Mariana C. Duarte, Lourena E. Costa, Vivian T. Martins, Rosângela F. Gomes, Maria N. Melo, Manuel Soto, Carlos Alberto P. Tavares & Eduardo Antonio F. Coelho. (2011) Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites. Parasitology Research 110:3, pages 1277-1285.
Crossref
Crossref
Javier Carrión, Cristina Folgueira, Manuel Soto, Manuel Fresno & Jose M Requena. (2011) Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation. Parasites & Vectors 4:1.
Crossref
Crossref
Shet Masih, Sunil K. Arora & Rakesh K. Vasishta. (2011) Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis. Experimental Parasitology 129:1, pages 55-64.
Crossref
Crossref
Laura Ramírez, Salvador Iborra, Jimena Cortés, Pedro Bonay, Carlos Alonso, Manoel Barral-Netto & Manuel Soto. (2010)
BALB/c Mice Vaccinated with
Leishmania major
Ribosomal Proteins Extracts Combined with CpG Oligodeoxynucleotides Become Resistant to Disease Caused by a Secondary Parasite Challenge
. Journal of Biomedicine and Biotechnology 2010, pages 1-9.
Crossref
Crossref
Camila I. de Oliveira, Ivan P. Nascimento, Aldina Barral, Manuel Soto & Manoel Barral-Netto. (2009) Challenges and perspectives in vaccination against leishmaniasis. Parasitology International 58:4, pages 319-324.
Crossref
Crossref
Sylvie Bertholet, Yasuyuki Goto, Lauren Carter, Ajay Bhatia, Randall F. Howard, Darrick Carter, Rhea N. Coler, Thomas S. Vedvick & Steven G. Reed. (2009) Optimized subunit vaccine protects against experimental leishmaniasis. Vaccine 27:50, pages 7036-7045.
Crossref
Crossref
Albert Kimutai, Willy K. Tonui, Michael M. Gicheru, Peter Kamau Ngure, Johnstone Ingonga, Stella Kepha, Laban Ireri Njeru, Dorcas Wachira, Robert Karanja Muhia, Milkah Mwangi & Lydia B. Nyamwamu. (2009) Evaluation of the adjuvanticity of artemisinin with soluble Leishmania major antigens in BALB/c mice. Journal of Nanjing Medical University 23:6, pages 359-372.
Crossref
Crossref
J. Carcelén, V. Iniesta, J. Fernández-Cotrina, F. Serrano, J.C. Parejo, I. Corraliza, A. Gallardo-Soler, F. Marañón, M. Soto, C. Alonso & C. Gómez-Nieto. (2009) The Chimerical Multi-Component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection. Vaccine 27:43, pages 5964-5973.
Crossref
Crossref
Márcia Dalastra Laurenti, Veruska Marques dos Santos Silveira, Nágila Francinete Costa Secundino, Carlos Eduardo Pereira Corbett & Paulo Paulocci Filemon Pimenta. (2009) Saliva of laboratory-reared Lutzomyia longipalpis exacerbates Leishmania (Leishmania) amazonensis infection more potently than saliva of wild-caught Lutzomyia longipalpis. Parasitology International 58:3, pages 220-226.
Crossref
Crossref
Virginie Woerly, Laurence Maynard, Annaële Sanquer & Hyone-Myong Eun. (2009) Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis. Parasitology Research 105:2.
Crossref
Crossref
Mahreen Ameen. (2009) Cutaneous leishmaniasis: disease susceptibility and pharmacogenetic implications. Pharmacogenomics 10:3, pages 451-461.
Crossref
Crossref
Manuel Soto, Laura Ramírez, Miguel A. Pineda, Victor M. González, Petter F. Entringer, Camila Indiani de Oliveira, Ivan P. Nascimento, Ana P. Souza, Laura Corvo, Carlos Alonso, Pedro Bonay, Claudia Brodskyn, Aldina Barral, Manoel Barral-Netto & Salvador Iborra. (2009) Searching Genes Encoding Leishmania Antigens for Diagnosis and Protection. Scholarly Research Exchange 2009, pages 1-25.
Crossref
Crossref
Rodolfo Cordeiro Giunchetti, Alexandre Barbosa Reis, Denise da Silveira-Lemos, Olindo Assis Martins-Filho, Rodrigo Corrêa-Oliveira, Jeffrey Bethony, André Macedo Vale, Josiane da Silva Quetz, Lilian Lacerda Bueno, João Carlos França-Silva, Evaldo Nascimento, Wilson Mayrink & Ricardo Toshio Fujiwara. (2008) Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis. Research in Veterinary Science 85:1, pages 106-112.
Crossref
Crossref
Javier Carrión, Cristina Folgueira & Carlos Alonso. (2008) Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells. Vaccine 26:20, pages 2537-2544.
Crossref
Crossref
Eugenia Carrillo, Martín Crusat, Javier Nieto, Carmen Chicharro, Maria del Carmen Thomas, Enrique Martínez, Basilio Valladares, Carmen Cañavate, Jose María Requena, Manuel Carlos López, Jorge Alvar & Javier Moreno. (2008) Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis. Vaccine 26:15, pages 1902-1911.
Crossref
Crossref
Clarisa B. Palatnik-de-Sousa. (2008) Vaccines for leishmaniasis in the fore coming 25 years. Vaccine 26:14, pages 1709-1724.
Crossref
Crossref
Javier Carrión, Cristina Folgueira & Carlos Alonso. (2008) Transitory or long-lasting immunity to Leishmania major infection: The result of immunogenicity and multicomponent properties of histone DNA vaccines. Vaccine 26:9, pages 1155-1165.
Crossref
Crossref
Ana M. Montalvo-Álvarez, Cristina Folgueira, Javier Carrión, Lianet Monzote-Fidalgo, Carmen Cañavate & Jose M. Requena. (2008)
The
Leishmania
HSP20 Is Antigenic during Natural Infections, but, as DNA Vaccine, It does not Protect BALB/c Mice against Experimental
L. amazonensis
Infection
. Journal of Biomedicine and Biotechnology 2008, pages 1-9.
Crossref
Crossref
Rodolfo Cordeiro Giunchetti, Rodrigo Corrêa-Oliveira, Olindo Assis Martins-Filho, Andréa Teixeira-Carvalho, Bruno Mendes Roatt, Rodrigo Dian de Oliveira Aguiar-Soares, Wendel Coura-Vital, Raquel Tropia de Abreu, Luiz Cosme Cotta Malaquias, Nelder Figueiredo Gontijo, Cláudia Brodskyn, Camila Indiani de Oliveira, Dirceu Joaquim Costa, Marta de Lana & Alexandre Barbosa Reis. (2008) A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs. Vaccine 26:5, pages 623-638.
Crossref
Crossref
Lianet Monzote Fidalgo. (2019)
Essential Oil from
Chenopodium ambrosioides
as a Promising Antileishmanial Agent
. Natural Product Communications 2:12, pages 1934578X0700201.
Crossref
Crossref
Saumyabrata Mazumder, Rajesh Ravindran, Antara Banerjee & Nahid Ali. (2007) Non-coding pDNA bearing immunostimulatory sequences co-entrapped with leishmanial antigens in cationic liposomes elicits almost complete protection against experimental visceral leishmaniasis in BALB/c mice. Vaccine 25:52, pages 8771-8781.
Crossref
Crossref
Vera Vinhas, Bruno B. Andrade, Fábio Paes, Andréa Bomura, Jorge Clarencio, José C. Miranda, André Báfica, Aldina Barral & Manoel Barral-Netto. (2007) Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector,Lutzomyia longipalpis. European Journal of Immunology 37:11, pages 3111-3121.
Crossref
Crossref
Richard Reithinger, Jean-Claude Dujardin, Hechmi Louzir, Claude Pirmez, Bruce Alexander & Simon Brooker. (2007) Cutaneous leishmaniasis. The Lancet Infectious Diseases 7:9, pages 581-596.
Crossref
Crossref
Sudipta Bhowmick, Rajesh Ravindran & Nahid Ali. (2007) Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response. Vaccine 25:35, pages 6544-6556.
Crossref
Crossref
Daniel Cláudio de Oliveira Gomes, Eduardo Fonseca Pinto, Luiz Dione Barbosa de Melo, Wallace Pacienza Lima, Vicente Larraga, Ulisses Gazos Lopes & Bartira Rossi-Bergmann. (2007) Intranasal delivery of naked DNA encoding the LACK antigen leads to protective immunity against visceral leishmaniasis in mice. Vaccine 25:12, pages 2168-2172.
Crossref
Crossref
Mark S. Bailey & Diana N.J. Lockwood. (2007) Cutaneous leishmaniasis. Clinics in Dermatology 25:2, pages 203-211.
Crossref
Crossref
J. CARRION, A. NIETO, S. IBORRA, V. INIESTA, M. SOTO, C. FOLGUEIRA, D. R. ABANADES, J. M. REQUENA & C. ALONSO. (2006) Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunology 28:5, pages 173-183.
Crossref
Crossref
Henry W Murray, Jonathan D Berman, Clive R Davies & Nancy G Saravia. (2005) Advances in leishmaniasis. The Lancet 366:9496, pages 1561-1577.
Crossref
Crossref
Salvador Iborra, Javier Carrión, Charles Anderson, Carlos Alonso, David Sacks & Manuel Soto. (2005)
Vaccination with the
Leishmania infantum
Acidic Ribosomal P0 Protein plus CpG Oligodeoxynucleotides Induces Protection against Cutaneous Leishmaniasis in C57BL/6 Mice but Does Not Prevent Progressive Disease in BALB/c Mice
. Infection and Immunity 73:9, pages 5842-5852.
Crossref
Crossref